Renal Artery Hemodynamic Co-Registration for Guided Denervation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current renal denervation (RDN) procedures for hypertension treatment have varying efficacy, with approximately 30% of patients showing no response or negative response due to physiological factors and inadequate therapy administration, lacking clear guidance on optimal treatment locations.

Innovation Solution

An RDN hemodynamics co-registration system that projects hemodynamic data onto fluoroscopic images during the procedure, using invasive measurements like iPWV to guide treatment device placement, predicting successful treatment locations and monitoring treatment progress.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If RDN procedure is performed without hemodynamic guidance, then procedure simplicity is maintained, but treatment efficacy decreases due to inability to predict successful treatment locations

Engineering Contradiction:
Improvetreatment efficacyVSAvoidprocedure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system performs preliminary hemodynamic measurements and co-registers them with angiographic images before and during the RDN procedure. This preliminary characterization of the renal artery hemodynamics allows the clinician to predict successful treatment locations in advance, enabling targeted intervention rather than blind treatment, thus improving reliability without requiring complex real-time adjustments during the procedure

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system introduces hemodynamic parameters (such as pulse wave velocity, stroke volume, and cardiac output) as intermediary metrics that bridge the gap between anatomical imaging and treatment outcome prediction. These hemodynamic metrics serve as mediators that translate physiological state into actionable guidance for treatment location selection, improving efficacy while maintaining procedural simplicity through automated analysis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If multiple treatment locations are evaluated, then treatment precision is improved, but measurement time increases

Engineering Contradiction:
Improvelocation-specific hemodynamic assessmentVSAvoidprocedure time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system continuously performs hemodynamic measurements and co-registration throughout the RDN procedure rather than performing separate discrete assessments. The intravascular catheter continuously samples hemodynamic parameters while being pulled back through the renal artery, and the system continuously co-registers these measurements with angiographic images, maintaining useful action throughout the procedure to assess multiple locations efficiently without significant time loss

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The system automatically performs the complex task of co-registering hemodynamic data with angiographic images and generating treatment guidance without requiring manual intervention. The automated co-registration algorithm processes the data streams in real-time, eliminating the need for time-consuming manual alignment and analysis, thus enabling precise multi-location assessment while minimizing time loss through self-service processing

Inventive Principle:
Principle #25Self-service

Data Source

PatentEP4681651A1Renal denervation treatment guidance using hemodynamic co-registration and associated systems, devices, methods
Publication Date: 2026.01.21 KONINKLIJKE PHILIPS NV
  • EP4681651A1 patent drawingFigure 1A~1B
  • EP4681651A1 patent drawingFigure 2
  • EP4681651A1 patent drawingFigure 3

AI summary

An apparatus includes a processor in communication with an intravascular catheter or guidewire. The processor controls the catheter or guidewire to obtain intravascular sensor measurements within a renal artery of a patient, and calculates hemodynamic values based on the intravascular sensor measurements. The hemodynamic values are associated with a suitability of the patient for a renal denervation treatment or an expected responsiveness of the patient to the treatment. The processor also performs co-registration between the hemodynamic values and a first X-ray image of the renal artery obtained with a contrast fluid inside the renal artery, and outputs, to a display, a screen display configured to guide a user regarding the renal denervation treatment. The screen display includes the first X-ray image of the renal artery and a representation of at least one hemodynamic value positioned proximate to at least one corresponding location along the length of the renal artery.